UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; a pharmacokinetics-based hypothesis

Psychoneuroendocrinology, 2016-11, Vol.73, p.9-15

2016

Volltextzugriff (PDF)

Cytochrome P450‐mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacy

British journal of clinical pharmacology, 2017-08, Vol.83 (8), p.1668-1675

2017

Volltextzugriff (PDF)

Effects of alexithymia and empathy on the neural processing of social and monetary rewards

Brain Structure and Function, 2017-07, Vol.222 (5), p.2235-2250

2017

Volltextzugriff (PDF)

Duloxetine enters the brain – But why is it not found in the cerebrospinal fluid

Journal of affective disorders, 2016-01, Vol.189, p.159-163

2016

Volltextzugriff (PDF)

Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment

Journal of clinical psychopharmacology, 2016-12, Vol.36 (6), p.554-561

2016

Volltextzugriff (PDF)

A Competitively Designed Version of the Point Subtraction Aggression Paradigm is Related to Proactive Aggressive and Psychopathic Traits in Males

Psychiatry research, 2017-10, Vol.256, p.318-327

2017

Volltextzugriff (PDF)

Pharmacokinetic patterns of risperidone-associated adverse drug reactions

European journal of clinical pharmacology, 2016-09, Vol.72 (9), p.1091-1098

2016

Volltextzugriff (PDF)

Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients – thinking of clinically relevant CYP2D6 interactions

Journal of psychopharmacology (Oxford), 2016-08, Vol.30 (8), p.803-809

2016

Volltextzugriff (PDF)

Pharmacokinetic considerations in antipsychotic augmentation strategies: How to combine risperidone with low-potency antipsychotics

Progress in neuro-psychopharmacology & biological psychiatry, 2017-06, Vol.76, p.101-106

2017

Volltextzugriff (PDF)

Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations?

International clinical psychopharmacology, 2016-09, Vol.31 (5), p.259

2016

Volltextzugriff (PDF)

Lamotrigine in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid, and cord blood

International clinical psychopharmacology, 2015-09, Vol.30 (5), p.249

2015

Volltextzugriff (PDF)

PS212. Effects of Proton Pump Inhibitors (PPI) on the Serum Concentrations of Venlafaxine

The international journal of neuropsychopharmacology, 2016-06, Vol.19 (Suppl_1), p.77-78

2016

Volltextzugriff (PDF)

Measuring citalopram in blood and cerebrospinal fluid: revealing a distribution pattern that differs from other antidepressants

International clinical psychopharmacology, 2016-05, Vol.31 (3), p.119

2016

Volltextzugriff (PDF)

Comparison of Clomethiazole and Diazepam in the Treatment of Alcohol Withdrawal Syndrome in Clinical Practice

European addiction research, 2017, Vol.23 (4), p.211-218

2017

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)

Erscheinungsjahr

n.n

Thema

Humans
(13)
Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Adult
(11)
Female
(11)
Male
(11)
Middle Aged
(9)
Psychiatry
(9)
Aged
(7)
Pharmacokinetics
(7)
Pharmacology & Pharmacy
(7)
Therapeutic Drug Monitoring
(7)
Young Adult
(7)
Adolescent
(6)
Aged, 80 And Over
(6)
Antipsychotic Agents - Blood
(5)
Neurosciences & Neurology
(5)
Risperidone - Blood
(5)
Antipsychotic Agents - Pharmacokinetics
(4)
Interaction
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Body mass index (BMI) but not body weight is associated with changes in the metabolism of risperidone; a pharmacokinetics-based hypothesis

Cytochrome P450‐mediated interaction between perazine and risperidone: implications for antipsychotic polypharmacy

Effects of alexithymia and empathy on the neural processing of social and monetary rewards

Duloxetine enters the brain – But why is it not found in the cerebrospinal fluid

Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment

A Competitively Designed Version of the Point Subtraction Aggression Paradigm is Related to Proactive Aggressive and Psychopathic Traits in Males

Pharmacokinetic patterns of risperidone-associated adverse drug reactions

Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients – thinking of clinically relevant CYP2D6 interactions

Pharmacokinetic considerations in antipsychotic augmentation strategies: How to combine risperidone with low-potency antipsychotics

Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations?

Lamotrigine in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid, and cord blood

PS212. Effects of Proton Pump Inhibitors (PPI) on the Serum Concentrations of Venlafaxine

Measuring citalopram in blood and cerebrospinal fluid: revealing a distribution pattern that differs from other antidepressants

Comparison of Clomethiazole and Diazepam in the Treatment of Alcohol Withdrawal Syndrome in Clinical Practice

Suchergebnisse filtern